2024探索生物类似药的潜力历史成就与未来前景研究报告-Unveiling the Potential of Biosimilars Past Achievements and Future Prospects.docx

AdisInsight

UnveilingthePotentialofBiosimilars:

PastAchievementsandFutureProspects

2

Unveiling

UnveilingthePotentialofBiosimilars:PastAchievementsandFutureProspects

Contents

Introduction

3

Biosimilarsversusgenerics

3

Advantagesofbiosimilars

3

Globaldistributionofbiosimilarsapprovals(5years)

4

Thefirstbiosimilar

9

Changeinregulatoryguidelinesfortheapprovalprocess

10

Interchangeablebiosimilars

10

Salesanalysisofreferencebiologicpostbiosimilarlaunch(2019-2023)

11

ComparativeaccountofYear-Over-Yearsalesofreferenceproducts

16

Globaldistributionoflaunchedbiosimilars

18

Keyplayersinthemarketforlaunchedbiosimilars

19

Thenextwaveofbiosimilars

20

Globaldistributionofupcomingbiosimilars

27

Keyplayersintheupcomingmarket

29

Conclusion

30

References

32

3

adisinsight

UnveilingthePotentialofBiosimilars:PastAchievementsandFutureProspects

Introduction

Biosimilarsaresafeandeffectivetreatmentoptionsformanyillnesses,suchaschronicskinandboweldiseases(likepsoriasis,irritablebowelsyndrome,Crohn’sdisease,andcolitis),arthritis,kidneyconditions,andcancer.Thesemedicinesareverycloseinstructureand

functiontobiologicmedicinesandincreaseaccesstolifesavingmedicationsatpotentiallylowercosts.Theyarehighlysimilartoabiologicmedicationalreadyapprovedbya

regulatorybody–theoriginalbiologic(alsocalledthereferenceproduct).

Bothabiosimilaranditsoriginalbiologic:

?Aremadefromthesametypesofsources(e.g.livingsources)

?Providethesamebenefitswhentreatingdiseasesormedicalconditions

?Areprovidedatthesamestrengthanddosage

?Arenotexpectedtocauseneworworseningsideeffects

Biosimilarsversusgenerics

BiosimilarsandGenericsarealte